These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
731 related articles for article (PubMed ID: 26389119)
21. Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis. He X; Tolosa MF; Zhang T; Goru SK; Ulloa Severino L; Misra PS; McEvoy CM; Caldwell L; Szeto SG; Gao F; Chen X; Atin C; Ki V; Vukosa N; Hu C; Zhang J; Yip C; Krizova A; Wrana JL; Yuen DA JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35191398 [TBL] [Abstract][Full Text] [Related]
22. YAP/TAZ: a promising target for squamous cell carcinoma treatment. Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073 [TBL] [Abstract][Full Text] [Related]
23. TGF-β/Smads signaling pathway, Hippo-YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases. Liu H; Sun M; Wu N; Liu B; Liu Q; Fan X Immun Inflamm Dis; 2023 Nov; 11(11):e1060. PubMed ID: 38018603 [TBL] [Abstract][Full Text] [Related]
24. YAP/TAZ: Molecular pathway and disease therapy. Wei Y; Hui VLZ; Chen Y; Han R; Han X; Guo Y MedComm (2020); 2023 Aug; 4(4):e340. PubMed ID: 37576865 [TBL] [Abstract][Full Text] [Related]
25. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells. Zhu H; Pan Y; Jiang Y; Li J; Zhang Y; Zhang S Hum Reprod; 2019 Apr; 34(4):635-645. PubMed ID: 30715393 [TBL] [Abstract][Full Text] [Related]
26. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy. Juan WC; Hong W Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805 [TBL] [Abstract][Full Text] [Related]
27. Modeling the Control of TGF-β/Smad Nuclear Accumulation by the Hippo Pathway Effectors, Taz/Yap. Labibi B; Bashkurov M; Wrana JL; Attisano L iScience; 2020 Aug; 23(8):101416. PubMed ID: 32798968 [TBL] [Abstract][Full Text] [Related]
29. The Hippo signaling pathway provides novel anti-cancer drug targets. Bae JS; Kim SM; Lee H Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075 [TBL] [Abstract][Full Text] [Related]
30. The hedgehog and Wnt/β-catenin system machinery mediate myofibroblast differentiation of LR-MSCs in pulmonary fibrogenesis. Chen X; Shi C; Cao H; Chen L; Hou J; Xiang Z; Hu K; Han X Cell Death Dis; 2018 May; 9(6):639. PubMed ID: 29844390 [TBL] [Abstract][Full Text] [Related]
31. M2 macrophages promote subconjunctival fibrosis through YAP/TAZ signalling. Wang Y; Geng X; Guo Z; Chu D; Liu R; Cheng B; Cui H; Li C; Li J; Li Z Ann Med; 2024 Dec; 56(1):2313680. PubMed ID: 38335557 [TBL] [Abstract][Full Text] [Related]
32. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation. Xu L; Cui WH; Zhou WC; Li DL; Li LC; Zhao P; Mo XT; Zhang Z; Gao J J Cell Mol Med; 2017 Aug; 21(8):1545-1554. PubMed ID: 28244647 [TBL] [Abstract][Full Text] [Related]
33. TGF β-1 and WNT Signaling Pathways Collaboration Associated with Cochlear Implantation Trauma-Induced Fibrosis. Bas E; Anwar MR; Van De Water TR Anat Rec (Hoboken); 2020 Mar; 303(3):608-618. PubMed ID: 30632705 [TBL] [Abstract][Full Text] [Related]
34. Epithelial Expression of YAP and TAZ Is Sequentially Required in Lung Development. Isago H; Mitani A; Mikami Y; Horie M; Urushiyama H; Hamamoto R; Terasaki Y; Nagase T Am J Respir Cell Mol Biol; 2020 Feb; 62(2):256-266. PubMed ID: 31486675 [TBL] [Abstract][Full Text] [Related]
35. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation. Kim W; Khan SK; Yang Y BMB Rep; 2017 Jan; 50(1):1-2. PubMed ID: 27881216 [TBL] [Abstract][Full Text] [Related]
36. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts. Cho N; Razipour SE; McCain ML Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479 [TBL] [Abstract][Full Text] [Related]
37. GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1. Zmajkovicova K; Bauer Y; Menyhart K; Schnoebelen M; Freti D; Boucher M; Renault B; Studer R; Birker-Robaczewska M; Klenk A; Nayler O; Gatfield J PLoS One; 2020; 15(2):e0228195. PubMed ID: 32053631 [TBL] [Abstract][Full Text] [Related]
38. Crosstalk between the TGF-β and WNT signalling pathways during cardiac fibrogenesis. Działo E; Tkacz K; Błyszczuk P Acta Biochim Pol; 2018; 65(3):341-349. PubMed ID: 30040870 [TBL] [Abstract][Full Text] [Related]
39. Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie's disease-derived fibroblasts via inhibition of YAP/TAZ nuclear translocation. Milenkovic U; Ilg MM; Zuccato C; Ramazani Y; De Ridder D; Albersen M BJU Int; 2019 Apr; 123(4):703-715. PubMed ID: 30536599 [TBL] [Abstract][Full Text] [Related]